Objectives. Musculoskeletal symptoms are common in SLE and are associated with significant
morbidity. However, assessing their nature can be challenging, with implications for …

… Md Yuzaiful Md Yusof , Md Yuzaiful Md Yusof … Lesley-Anne Bissell, Md Yuzaiful Md Yusof,
Maya H. Buch, Primary myocardial disease in scleroderma—a comprehensive review of the …

Interleukin (IL)-6 is a potent pro-inflammatory agent that plays a crucial role in the pathogenesis
of systemic inflammatory disease. Targeting this pathway in rheumatoid arthritis (RA) …

… The scans were scored independently by two radiologists (MD, a chest radiologist with >10
years experience in reporting ILD, and GL, a general radiologist), both blinded to lung …

Autoimmune connective tissue diseases arise in a stepwise fashion from asymptomatic
preclinical autoimmunity. Type I interferons have a crucial role in the progression to established …

Objective To evaluate predictors of serious infection events ( SIE s) during rituximab ( RTX )
therapy and effects of hypogammaglobulinemia on SIE rates, and humoral response and its …

Objective The immunopathogenesis of systemic lupus erythematosus (SLE) is heterogeneous,
and responses of skin to rituximab are variable. This study was undertaken to determine …

Objective To assess factors associated with primary and secondary non-response to rituximab
in systemic lupus erythematosus (SLE) and evaluate management of secondary non-…

Objective To evaluate clinical, interferon and imaging predictors of progression from ‘At Risk’
to autoimmune connective tissue diseases (AI-CTDs). Methods A prospective observational …

… Md Yuzaiful Md Yusof … Correspondence to: Dr Md Yuzaiful Md Yusof, Leeds Institute of
Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds …